KCD 232

Known as: KCD-232 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The objective of this study was to determine the gender difference in the craniofacial relationship of skeletal, dental and soft… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 5
Is this relevant?
2002
2002
" # $&% '( ) $ * + ! &, $ ! /."01 2 34 !* # ) 5 # $ %6 7 !* 89 ! " 3: !* ; < 9 <$/ # ! ; '1 !* = /.?>:* ? @8A 5 # ! $ ! B'7 ! C… (More)
Is this relevant?
1987
1987
The effect of some hypolipidemic agents, which are commercially available and those being developed, on certain biochemical… (More)
Is this relevant?
1985
1985
The effects of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232), a new hypolipidemic agent, on serum cholesterol level and… (More)
Is this relevant?
1985
1985
Changes in serum lipoprotein profiles were characterized in Donryu rats subcutaneously implanted with an ascites hepatoma line of… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
1985
1985
The effect of 4-(4'-chlorobenzyloxy)benzoic acid (MII), a metabolite of a new hypolipidemic agent 4-(4'-chlorobenzyloxy)benzyl… (More)
Is this relevant?
1984
1984
The effects of KCD-232, a new hypolipidemic agent with a structure of 4-(4'-chlorobenzyloxy) benzyl nicotinate, on triglyceride… (More)
Is this relevant?
1984
1984
Nephrotic syndrome is characterized by renal damage, protein urina, hypoproteinemia and edema with marked hypercholesterolemia… (More)
Is this relevant?